Percutaneous management of late leak after lariat transcatheter ligation of the left atrial appendage in patients with atrial fibrillation at high risk for stroke

Catheterization and Cardiovascular Interventions

Volumn 83, Issue 4, 2014, Pages 664-669

  Mosley II, William J ^a   Smith, Michael R ^a   Price, Matthew J ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

atrial fibrillation; Lariat; left atrial appendage; left atrial appendage occlusion; stroke; thromboembolism

Indexed keywords

ADVERSE EFFECTS; AGED; ATRIAL FIBRILLATION; CASE REPORT; COLOR DOPPLER ECHOCARDIOGRAPHY; COMPLICATION; DEVICES; ECHOGRAPHY; HEART ATRIUM APPENDAGE; HEART CATHETERIZATION; HUMAN; LIGATION; MALE; MIDDLE AGED; RADIOGRAPHY; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HUMANS; LIGATION; MALE; MIDDLE AGED; STROKE; TREATMENT OUTCOME;

EID: 84894273282     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25251     Document Type: Article

References (11)

1. Ganjehei L, Massumi A, Razavi M, Rasekh A,. Stroke prevention in nonvalvular atrial fibrillation. Text Heart Inst J 2011; 38: 350-352.
2. Fuster V, Ryden LE, Cannom DS, et al. 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2011; 57: e101-e198.
3. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
4. Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-992.
5. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-891.
6. Madden JL,. Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli. J Am Med Assoc 1949; 140: 769-772.
7. Dawson AG, Asopa S, Dunning J,. Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion? Interact Cardiovasc Thorac Surg 2010; 10: 306-311.
8. Katz ES, Tsiamtsiouris T, Applebaum RM, Schwartzbard A, Tunick PA, Kronzon I,. Surgical left atrial appendage ligation is frequently incomplete: A transesophageal echocardiograhic study. J Am Coll Cardiol 2000; 36: 468-471.
9. Bartus K, Han FT, Bednarek J, et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol 2013; 62: 108-118.
10. Massumi A, Chelu MG, Nazeri A, et al. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol 2013; 111: 869-873.
11. Viles-Gonzalez JF, Kar S, Douglas P, et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: A PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol 2012; 59: 923-929.